1. Establishment and application of SPA-co-operated ELISA for detection of anti-HCV-IgM
- Author
-
Hao Lj, Z Q Yu, X W Yuan, Y K Wang, Fang‐He Li, J Y Qi, and L S Guo
- Subjects
Hepatitis ,medicine.medical_specialty ,biology ,Anti hiv ,business.industry ,Enzyme-Linked Immunosorbent Assay ,Hepatitis C ,Hepatitis C Antibodies ,medicine.disease ,Horseradish peroxidase ,Immunoglobulin M ,Antigen ,Management of Technology and Innovation ,Epidemiology ,Staphylococcus aureus protein A ,Immunology ,medicine ,biology.protein ,Humans ,Hepatitis Antibodies ,Staphylococcal Protein A ,business ,Acute hepatitis - Abstract
A staphylococcus aureus protein A co-operated ELISA (SPA-ELISA) for the detection of anti-HCV-IgM has been established using HCV antigenic polypeptide, SPA-bearing germs and horseradish peroxidase labelled anti-human IgM. The specificity of SPA-ELISA has been confirmed by some substitution tests, blocking tests and destroying test with 2-mercaptoethanol. The results showed that the rate of anti-HCV-IgG in a group of patients with acute hepatitis and there were significant difference in anti-HCV-IgM was higher than that of anti-HCV-IgM detected rates between patients with acute hepatitis and those with chronic hepatitis (32.26%, P < 0.01). On the other hand, the positive rates of anti-HCV-IgM were 53.66% and 63.41% in transfusion associated hepatitis, 38.10% and 42.86% in sporadic hepatitis, 6.11% and 16.33% in people who have had active social activities, 40.00% and 10.00% in a group of blood donors respectively. Furthermore, taking into account the characteristics of HCV polypeptide used, its easiness of manipulation, and elimination of the interference of anti-HCV-IgG in sera, the new SPA-ELISA is believed to be of practical value in clinical and epidemiological studies of hepatitis C.
- Published
- 1993
- Full Text
- View/download PDF